TITLE

Risperdal Recall

PUB. DATE
July 2011
SOURCE
Pharmaceutical Representative;Jul2011, Vol. 41 Issue 7, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the move of Ortho-McNeil-Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, to initiate a voluntary recall of its antipsychotic medication Risperdal due to unsual odor.
ACCESSION #
63483069

 

Related Articles

  • Retin-A update. Lebowitz, L. // Self;Feb92, Vol. 14 Issue 2, p26 

    Reports that now that Ortho Pharmaceutical's 17-year patent for Retin-A has run out, competitors are racing to bring name brands of tretinoin, the generic term for the active ingredient in Retin-A, to market. Stumbling blocks; Advanced Polymer Systems may be Ortho's biggest competitor; Ironies.

  • Refillable compact dispenses daily dose. Abrams, Bernard // Packaging Digest;Feb2000, Vol. 37 Issue 2, p37 

    Reports on the packaging of oral contraceptives manufactured by Raritan, New Jersey-based Ortho-McNeil Inc. Features of the Ortho Personal Pak introduced in January 2000; Reversal of normal procedure for Dialpak; Advantages of having reusable dispensers.

  • J&J unleashing $50 mil to launch Renova skin cream. Sloan, Pat // Advertising Age;6/3/1996, Vol. 67 Issue 23, p3 

    Relates that Johnson & Johnson's Ortho Pharmaceuticals unit will spend $50 million in marketing money on its prescription skin cream Renova. A print campaign for the product approved by the United States Food & Drug Administration; Approval for a television advertisement expected to follow; A...

  • New kid in town. Korman, Lorraine // American Salon;Jun96, Vol. 119 Issue 6, p32 

    Features the wrinkle-fighter extant Renova from Ortho Pharmaceutical Corp., approved by the Food and Drug Administration. Tretinoin as active ingredient; Lessening of dryness and reddening side effects.

  • Ortho's $45 million expansion to consolidate oral-contraceptives operation in Manati. M.M. // Caribbean Business;6/26/2003, Vol. 31 Issue 25, p16 

    Focuses on the expansion of Ortho Pharmaceuticals in Puerto Rico. Number of additional jobs; Consolidation of oral contraceptives with manufacturing operations.

  • Ortho Tri-Cyclen--`two thumbs up'. Dickinson, James G. // Medical Marketing & Media;Feb99, Vol. 34 Issue 2, p36 

    Reports on the United States Food & Drug Administration's (FDA) endorsement of Ortho Pharmaceuticals Corp.'s advertisement for its Ortho Tri-Cyclen contraceptive.

  • Youth serum. Murray, Mary // Vogue;Mar96, Vol. 186 Issue 3, p424 

    Focuses on Ortho Pharmaceutical's Renova, a US Food & Drug Administration- (FDA) approved wrinkle fighter. Active ingredient of the skin cream; Benefits of the anti-wrinkle cream; Side effects.

  • Tapentadol Immediaterelease Tablets C-II (Nucyntaâ„¢). Elliott, William T.; Chan, James // Internal Medicine Alert;8/15/2009, Vol. 31 Issue 15, p117 

    The article offers information about a new opioid analgesic called Tapentadol released by Pricara, a part of the Ortho-McNeil-Janssen Pharmaceuticals Inc. and discusses a study regarding the effectiveness of the drug.

  • Topamax warnings stronger.  // Drug Utilization Review;Nov2001, Vol. 17 Issue 11, p8 

    Reports on the strengthened warning and precautions sections in the label of anticonvulsants Topamax tablets and Sprinkle capsules from Ortho-McNeil company. Indications; Side effects; Treatment of side effects.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics